Skip to main content

Day: April 12, 2021

Mettler-Toledo International Inc. to Host First Quarter 2021 Earnings Conference Call

COLUMBUS, Ohio, April 12, 2021 (GLOBE NEWSWIRE) — Mettler-Toledo International Inc. (NYSE:MTD) today announced it will host a conference call to discuss the Company’s quarterly results on Thursday, May 6, 2021 at 5:00 p.m. Eastern Time. To hear a live webcast of the call, visit www.mt.com/investors on the Company’s website. A replay of the webcast will be available until May 10, 2021.         METTLER TOLEDO (NYSE: MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our solutions are critical in key R&D, quality control, and manufacturing processes for customers in a wide range of industries including life sciences, food,...

Continue reading

Angi Inc. Monthly Metrics Available on IAC IR Site

NEW YORK, April 12, 2021 (GLOBE NEWSWIRE) — IAC (NASDAQ: IAC) posted monthly metrics for March 2021, including metrics for Angi Inc. (NASDAQ: ANGI), on the investor relations section of the IAC website at https://ir.iac.com/. About Angi Inc.Angi Inc. (NASDAQ: ANGI) is your home for everything home—a comprehensive solution for all your home needs. From repairs and renovations to products and financing, Angi is transforming every touch point in the customer journey. With over 25 years of experience and a network of nearly 250,000 pros, we have helped more than 150 million people with their home needs. Angi is your partner for every part of your home care journey. About IACIAC builds companies. We are guided by curiosity, a questioning of the status quo, and a desire to invent or acquire new products and brands. From the single seed...

Continue reading

HAWKINS, INC. TO PARTICIPATE IN 2021 VIRTUAL WELLS FARGO INDUSTRIALS CONFERENCE

Roseville, MN, April 12, 2021 (GLOBE NEWSWIRE) — Hawkins, Inc. (Nasdaq: HWKN), a leading specialty chemical company, today announced that it will participate in the 2021 Virtual Wells Fargo Industrials Conference to be held May 5 and 6.  Hawkins will join nearly 50 other companies in this virtual conference.  The conference will consist of 30-minute fireside chats, topical panels, and one-on-one meetings with senior executives from leading machinery, aerospace & defense, electrical and industrial products, chemicals and automotive & mobility companies. Hawkins management will also be available for one-on-one meetings throughout the conference.  For more information about the conference or to schedule a one-on-one meeting with management, please contact your Wells Fargo representative or ir@hawkinsinc.com. About Hawkins,...

Continue reading

Seer to Report First Quarter Financial Results on May 10, 2021

REDWOOD CITY, Calif., April 12, 2021 (GLOBE NEWSWIRE) — Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report financial results for the first quarter 2021 after market close on Monday, May 10, 2021. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the Investor section of Seer’s website at investor.seer.bio. An archived replay will be available on the company’s website following the event. About SeerSeer is a life sciences company focused on enabling exceptional scientific outcomes by commercializing transformative products that will drive breakthrough ideas by unlocking the deep, unbiased biological information that can make them...

Continue reading

Bioventus to Release First Quarter of Fiscal Year 2021 Financial Results on May 12, 2021

DURHAM, N.C., April 12, 2021 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that first quarter of fiscal year 2021 financial results will be released after the market closes on Wednesday, May 12, 2021. Management will host a conference call to discuss its financial results and provide a business update, with a question and answer session, at 5:00 p.m. Eastern Time on May 12, 2021. Those who would like to participate may dial 844-945-2085 (442-268-1266 for international callers) and provide access code 8976184. A live webcast of the call and any accompanying materials will also be provided on the investor relations section of the Company’s website at https://ir.bioventus.com/. The webcast will be archived on the Company’s website...

Continue reading

3D Systems Announces Date of First Quarter 2021 Financial Results

ROCK HILL, S.C., April 12, 2021 (GLOBE NEWSWIRE) — 3D Systems (NYSE:DDD) announced today it will release its financial results for the first quarter of 2021 and file its Form 10-Q after the U.S. stock markets close on Monday, May 10, 2021. The company will hold a conference call and simultaneous webcast to discuss these financial results on Tuesday, May 11, 2021, at 8:30 a.m. Eastern Time.First Quarter 2021 Results Conference Call  Date: Tuesday, May 11, 2021  Time: 8:30 a.m. Eastern Time  Listen via webcast: www.3dsystems.com/investor  Participate via telephone: 201-689-8345  The webcast replay will be available approximately two hours after the end of the conference call at www.3dsystems.com/investor.Forward-Looking StatementsCertain statements made in this release that are not statements of historical or...

Continue reading

Crinetics Pharmaceuticals Announces Closing of Common Stock Offering

SAN DIEGO, April 12, 2021 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, announced today that it has closed its previously announced underwritten follow-on offering of 4,562,044 shares of its common stock at a price to the public of $16.44 per share. The gross proceeds to Crinetics from the offering, before deducting the underwriting discounts and commissions and other offering expenses, were approximately $75.0 million. Investors in the offering included Deep Track Capital, Bain Capital Life Sciences, and Driehaus Capital Management, with participation from other new and existing stockholders. Crinetics intends to use the net proceeds...

Continue reading

Berkeley Lights to Report First Quarter 2021 Financial Results on May 11, 2021

EMERYVILLE, Calif., April 12, 2021 (GLOBE NEWSWIRE) — Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be reporting financial results for the first quarter 2021 before market open on Tuesday, May 11, 2021. Company management will be webcasting a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time. Live audio of the webcast will be available on the “Investors” section of the Company’s website at: www.berkeleylights.com. The webcast will be archived and available for replay after the event. About Berkeley Lights Berkeley Lights is a leading digital cell biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products for our customers. The Berkeley Lights Platform...

Continue reading

Adaptive Biotechnologies to Report First Quarter Financial Results on May 5, 2021

SEATTLE, April 12, 2021 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT)  a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will report financial results for the first quarter 2021 after market close on Wednesday, May 5, 2021. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the “Investors” section of the company website at: www.adaptivebiotech.com. The webcast will be archived and available for replay within 24 hours after the event. About Adaptive BiotechnologiesAdaptive Biotechnologies is a commercial-stage biotechnology company focused on harnessing the...

Continue reading

FormFactor Introduces Automated Cryogenic System to Accelerate Quantum Computing Development

LIVERMORE, Calif., April 12, 2021 (GLOBE NEWSWIRE) — FormFactor, Inc. (NASDAQ:FORM), a leading semiconductor test and measurement supplier, today launched its first product for the emerging quantum computing market, the HPD IQ1000, a scanning SQUID (Superconducting Quantum Interference Device) microscope. With rapid scan speed and process automation, the IQ1000 is the first commercial product of its kind to enable unattended and high-throughput characterization of trapped magnetic flux in superconducting circuits. Device designers can now eliminate the guesswork involved in the design of resilient superconducting circuits, and significantly reduce development time by locating and capturing detrimental magnetic vortices to enhance device performance.    Device characterization is a requisite for the development of the established...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.